Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...
  • 3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
  • 3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...
  • 3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...
  • 3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
  • 3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China
  • 3/21/2025Junshi's Toripalimab Receives 11th Approval in China
  • 3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials
  • 3/21/2025AZ's Calquence (Acalabrutinib) Receives New Approval in China for Firs...
  • 3/21/2025Gilead's Trodelvy Receives Second Approval in China
  • 3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...
  • 3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...
  • 3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...
  • 3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint
  • 3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China
  • 3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS
  • 3/19/2025CSPC Initiates Phase 3 Trial of SYS6010 for EGFR-Mutant NSCLC Patients
  • 3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...
  • 3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...
  • 3/17/2025Visirna Announce Positive Topline Results from Phase 3 Trial of Ploza...
  • 3/17/2025SinoCellTech Advances PD-1/VEGF Bispecific SCTB14 into Phase 2/3 for E...
  • 3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China
  • 3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...
  • 3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China
  • 3/14/2025Pyrotech's PTT-936 Gains Approval for Clinical Trials in China for Adv...
  • 3/14/2025Roche's Itovebi (Inavolisib) Wins Approval in China for Advanced Breas...
  • 3/13/2025AskBio Receives FDA Regenerative Medicine Advanced Therapy designation...
  • 3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...
  • 3/12/2025Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Approval in China
  • 3/12/2025CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 for Advanced HNSC...
  • Page:2/11 Total number of articles:316: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group